pyrazines has been researched along with Cancer of the Retina in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Chen, X; Ge, J; Han, X; Qiu, J; Wu, C; Wu, N; Wu, Y; Yang, M; Yang, Y; Yu, K; Yu, N; Zhang, J; Zhuang, J | 1 |
| Kotoula, V; McMillin, D; Miller, JW; Mitsiades, CS; Mitsiades, N; Negri, J; Poulaki, V | 1 |
2 other study(ies) available for pyrazines and Cancer of the Retina
| Article | Year |
|---|---|
Tetramethylpyrazine downregulates transcription of the CXC receptor 4 (CXCR4) via nuclear respiratory factor‑1 (Nrf‑1) in WERI‑Rb1 retinoblastoma cells.
Topics: Animals; Apoptosis; Biomarkers, Tumor; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Nuclear Respiratory Factor 1; Pyrazines; Receptors, CXCR4; Retinal Neoplasms; Retinoblastoma; Transcription, Genetic; Tumor Cells, Cultured; Vasodilator Agents; Xenograft Model Antitumor Assays | 2019 |
The proteasome inhibitor bortezomib induces apoptosis in human retinoblastoma cell lines in vitro.
Topics: Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Boronic Acids; Bortezomib; Caspases; Cell Proliferation; Flow Cytometry; Formazans; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Immunoblotting; Indicators and Reagents; Neoplasm Proteins; Oligonucleotide Array Sequence Analysis; Protease Inhibitors; Pyrazines; Retinal Neoplasms; Retinoblastoma; Reverse Transcriptase Polymerase Chain Reaction; Tetrazolium Salts; Tumor Cells, Cultured; Up-Regulation | 2007 |